Celebrating 40 years of the cloning of the TCR. A landmark in immunology!!!

Recent approvals have made EGFR inhibitors available to more patients with lung cancer. Check out this schematic and the #AACRBlog to make sense of the approved indications: bit.ly/3ZplN81 FDA Oncology

#numeridelcancro 2024: vi aspettiamo insieme ad AIOM a Palazzo Baldassini, Roma, per la conferenza stampa di presentazione della nuova edizione. #fondazioneaiom #oncologia #numeridelcancro2024

Glad to share our commentary on a great nature papeer on #immune equilibrium of #breastcancer precursors! #threeEs #threeCs #CancerResearch #immunotherapy with Ilio Vitale and co. Available at rdcu.be/d3nGi Fox Chase Cancer Center

Manca poco al #wcd2025. Al centro della campagna di comunicazione di quest'anno c'è un nuovo approccio assistenziale in #oncologia, centrato pienamente sulla persona. #AIOM #worldcancerday25 #giornatamondialecontroilcancro #unitedbyunique

PhD Students - Here are the 50 most useful tools for researchers. 𝐋𝐢𝐭𝐞𝐫𝐚𝐭𝐮𝐫𝐞 𝐑𝐞𝐯𝐢𝐞𝐰 1. Litmaps 2. @ResearchPal 3. Connected Papers 4. Scite 5. AnswerThis 6. Semantic Scholar 7. R Discovery 8. PubMed 9. Zotero 10. EndNote 11. Elsevier | Mendeley

The relative stability of body weight over time in any given person suggests a highly sophisticated metabolic machinery that is capable of regulating a multitude of variables, both predictable (e.g., basal metabolic rate) and unpredictable (e.g., quality and quantity of food

#CervicalCancerAwarenessMonth World Health Organization (WHO) launched the #CervicalCancer Elimination Initiative in 2020. The goal🥅: to eliminate #CxCa as a public health problem by 2100. To achieve this, countries must reach & maintain incidence rate of <4 new cases/100K women/yr iarc.who.int/featured-news/…

WHO expresses deep concern about the implications of the immediate funding pause for #HIV programmes in low- and middle-income countries. These programmes provide access to life-saving HIV therapy to more than 30 million people worldwide. A funding halt for HIV programmes can

L’AIOM lancia un messaggio nella Giornata mondiale contro il #cancro che si celebra oggi: medici e operatori sanitari devono invitare tutti a condurre uno stile di vita sano. L’obesità è infatti correlata a 12 diversi tipi di #tumore. #ANSASalute ansa.it//canale_salute…

Grande partecipazione oggi a Roma a Palazzo Baldassini per il Convegno Nazionale #AIOM e Fondazione AIOM per il #worldcancerday. #wcd25 #unitedbyunique #giornatamondialecontroilcancro

16/ When you hear, "the CDC's Epidemic Intelligence Service class was cancelled and the officers fired" I hope this gives you a sense of what has been lost. Not just the outbreaks that can't be investigated, the surge capacity gone, but our future public health leadership lost

Fanconi Anemia (FA) manifests as aplastic anemia, cancer predisposition, and developmental defects including hypogonadism, microcephaly, and other organ failure. DOUG GREEN suggest that developmental defects in FA may not solely stem from DNA repair deficiencies but could also

Every minute, 4 women are diagnosed with #BreastCancer 🗺️wide & 1 woman dies from the disease. All stakeholders, particularly govts, can mitigate or reverse these trends by adopting primary prevention policies, & by investing in early detection & treatment iarc.who.int/news-events/br…

😞Italy lags behind with phase I trials in oncology. 😒 And the investigator-driven ones are only a minority

Una storia straordinaria, una grande vittoria della scienza e della medicina. Guardate bene questo bimbo, di cui si conoscono solo le iniziali, KJ. KJ, nato con una rarissima malattia genetica letale (deficit di CPS1), è il primo paziente al mondo 1/

Cancer of unknown primary site encompasses a heterogeneous group of metastatic cancers with an unidentified primary site of origin. Putative site-specific therapy and empirical chemotherapy are acceptable treatment options. Read the Clinical Practice article “Cancer of Unknown

🧵1/ 🚨 Thrilled to announce the simultaneous publication of our fellowship project during #ASCO25 in #Chicago! We analyzed 50 phase 3 cancer trials published in top journals in 2023. 👇 What we found was eye-opening. #CommonSenseOncology

Targeting DNA damage in ageing: towards supercharging DNA repair nature.com/articles/s4157… This new Review discusses approaches to pharmacologically mitigate the adverse effects of DNA damage to prevent mutation-driven cancers and mitigate age-related degenerative diseases

Why do some people who have mutations of familial Alzheimer's do not get the disease? They have protective genomic variants. A first-rate review The Lancet Neurology thelancet.com/journals/laneu…